Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells

被引:517
作者
Trettel, F
Rigamonti, D
Hilditch-Maguire, P
Wheeler, VC
Sharp, AH
Persichetti, F
Cattaneo, E
MacDonald, ME
机构
[1] Massachusetts Gen Hosp, Mol Neurogenet Lab, Charlestown, MA 02129 USA
[2] Univ Milan, Inst Pharmacol Sci, I-20133 Milan, Italy
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA
关键词
D O I
10.1093/hmg/9.19.2799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lengthening a glutamine tract in huntingtin confers a dominant attribute that initiates degeneration of striatal neurons in Huntington's disease (HD). To identify pathways that ave candidates for the mutant protein's abnormal function, we compared striatal cell lines established from wild-type and Hdh(Q111) knock-in embryos. Alternate versions of full-length huntingtin, distinguished by epitope accessibility, were localized to different sets of nuclear and perinuclear organelles involved in RNA biogenesis and membrane trafficking, However, mutant STHdh(Q111) cells also exhibited additional forms of the full-length mutant protein and displayed dominant phenotypes that did not mirror phenotypes caused by either huntingtin deficiency or excess. These phenotypes; indicate a disruption of striatal cell homeostasis by the mutant protein, via a mechanism that is separate front its normal activity. They also support specific stress pathways, including elevated p53, endoplasmic reticulum stress response and hypoxia, as potential players in HD.
引用
收藏
页码:2799 / 2809
页数:11
相关论文
共 47 条
[1]   Mice without telomerase: what can they teach us about human cancer? [J].
Artandi, SE ;
DePinho, RA .
NATURE MEDICINE, 2000, 6 (08) :852-855
[2]   Stress signals utilize multiple pathways to stabilize p53 [J].
Ashcroft, M ;
Taya, Y ;
Vousden, KH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) :3224-3233
[3]   Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin [J].
Boutell, JM ;
Thomas, P ;
Neal, JW ;
Weston, VJ ;
Duce, J ;
Harper, PS ;
Jones, AL .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1647-1655
[4]  
Browne SE, 1999, BRAIN PATHOL, V9, P147
[5]  
Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO
[6]  
2-7
[7]  
Chai YH, 1999, J NEUROSCI, V19, P10338
[8]   Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice [J].
Cummings, CJ ;
Reinstein, E ;
Sun, YL ;
Antalffy, B ;
Jiang, YH ;
Ciechanover, A ;
Orr, HT ;
Beaudet, AL ;
Zoghbi, HY .
NEURON, 1999, 24 (04) :879-892
[9]   Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 [J].
Cummings, CJ ;
Mancini, MA ;
Antalffy, B ;
DeFranco, DB ;
Orr, HT ;
Zoghbi, HY .
NATURE GENETICS, 1998, 19 (02) :148-154
[10]   Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation [J].
DeRooij, KE ;
Dorsman, JC ;
Smoor, MA ;
DenDunnen, JT ;
VanOmmen, GJB .
HUMAN MOLECULAR GENETICS, 1996, 5 (08) :1093-1099